|
|
||||||||
HEALTH POLICY AND ETHICS FORUM |
Correspondence: Requests for reprints should be sent to Tikki Pang, Research Policy and Cooperation (RPC/EIP), World Health Organization, Ave Appia, CH-1211 Geneva 27, Switzerland (e-mail: pangt{at}who.int).
Ensuring that advances in genomics are applied to the health improvement of people living in developing countries is an important contemporary challenge. In the near term, such advances are likely to alleviate infectious diseases, with longer-term benefits envisaged for chronic disorders.
To ensure that benefits are shared by developing countries, attention must be paid to complex ethical, legal, social, and economic issues, as well as to public education and engagement. Creative and equitable international mechanisms and goodwill are needed to turn high hopes into reality and allow the use of genomics to reduce health inequities between rich and poor nations. (Am J Public Health. 2002;92:10771079)
Related articles in AJPH:
This article has been cited by other articles:
![]() |
R. P. Ojha and R. Thertulien Health Care Policy Issues as a Result of the Genetic Revolution: Implications for Public Health Am J Public Health, March 1, 2005; 95(3): 385 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Halliday, V. R Collins, M. A. Aitken, M. P M Richards, and C. A Olsson Genetics and public health--evolution, or revolution? J Epidemiol Community Health, November 1, 2004; 58(11): 894 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Wedeen ETHICS IN PUBLIC HEALTH INSTITUTIONS Am J Public Health, December 1, 2002; 92(12): 1884 - 1885. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |